Showing results (111-120 of 499) with videos related to
Sort By:
Pageof 50
Expert Opinion on Therapeutic Targets|December 13, 2016
MERS-CoV spike protein: a key target for antiviralsLanying Du, Yang Yang, Yusen Zhou, et al.Journal of Virology|July 2, 2010
Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitorYun Zhu, Lu Lu, Liling Xu, et al.BMC Infectious Diseases|May 2, 2002
Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundlesA Robert Neurath, Nathan Strick, Shibo Jiang, et al.FEBS Letters|August 15, 2006
Identification of the HIV-1 gp41 core-binding motif--HXXNPFJing-He Huang, Zu-Qiang Liu, Shuwen Liu, et al.Vaccine|April 20, 2005
rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigensAngus J MacDonald, Long Cao, Yuxian He, et al.AIDS Research and Human Retroviruses|October 25, 2002
XTT formazan widely used to detect cell viability inhibits HIV type 1 infection in vitro by targeting gp41Qian Zhao, Justin T Ernst, Andrew D Hamilton, et al.Viruses|January 25, 2013
Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocketFei Yu, Lu Lu, Lanying Du, et al.Nature Reviews. Microbiology|February 10, 2009
The spike protein of SARS-CoV--a target for vaccine and therapeutic developmentLanying Du, Yuxian He, Yusen Zhou, et al.Antimicrobial Agents and Chemotherapy|October 27, 2004
N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusionShibo Jiang, Hong Lu, Shuwen Liu, et al.Microbes and Infection|May 1, 2013
Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in ChinaQi Liu, Lu Lu, Zhiwu Sun, et al.Pageof 50